News and stories

Read the latest news, research, and achievements made by the BME community

What Sits at the Centre of Wound Healing?

October 19, 2021 | The science of rapid wound healing has new insights due to discoveries in fruit flies from the Fernandez-Gonzalez lab at University of Toronto. Collaboration, community and perseverance has resulted in an article published in the journal Cell Reports as “p38-mediated cell growth and survival drive rapid embryonic wound repair”.

Medicine by Design and partners invite trainees to explore entrepreneurship through enhanced Building a Biotech Venture program

October 15, 2021 | Building a Biotech Venture, a trainee entrepreneurship program, is going into its second year with expanded education and support for trainees who are thinking about taking their first steps toward building their research into a product or venture.

New Medicine by Design-funded method for testing muscle repair in a dish to impact development of stem cell-based therapies

October 7, 2021 | Scientists out of two labs at the University of Toronto have discovered a novel way to test self-repair of skeletal muscle, and this method has the potential to rapidly advance the development of treatments for diseases like muscular dystrophy (MD) and other degenerative muscle conditions.

Events, talks, and bulletin board

Stay informed about events hosted by BME and our affiliated organizations

Industry & Alumni Speaker Series – Kevin Ming
Oct 25 @ 12:00 pm – 1:00 pm

Industry & Alumni Speaker Series

Kevin Ming, PhD R&D Chief of Staff VitalBio

An Engineer’s Journey into Business

October 25, 2021 12:00pm – 1:00pm
Bio: Kevin Ming is an experienced business executive with an extensive background in technology and innovation. Kevin received his B.Sc. in Electrical Engineering from Queen’s University, M.A.Sc. in Electrical Engineering from the University of British Columbia, and Ph.D. in Biomedical Engineering from the University of Toronto, where he developed a smartphone-based point-of-care infectious disease diagnostic device. With over 10 years of experience in the innovation space, his first venture was the co-founding of a food allergy technology start-up that spun out of another University of Toronto project. After graduation he joined Haltech Regional Innovation Centre, where he worked with and advised over 200 start-ups in sectors spanning Digital Health, IT & Software, Advanced Manufacturing, Clean Tech, as well as others. Kevin has held leadership roles at Haltech (Executive Director), Enghouse Systems Ltd. (Director of Growth), and most recently Vital Biosciences Inc. (R&D Chief of Staff) where he is implementing strategic initiatives and improving product development processes in order to help “reinvent lab testing for 7.6 billion people.”
Synthetic Biology: Life Redesigned, with James Collins from the Massachusetts Institute of Technology. @ Online
Oct 27 @ 12:00 pm – 1:00 pm

Synthetic Biology: Life Redesigned, with James Collins from the Massachusetts Institute of Technology.

The lecture will take place on Wednesday October 27, from 12-1PM (Eastern Time) on Zoom and will be recorded. For security purposes, you must have a Zoom account to access the lecture.

External members are required to register at to receive the link and passcode. Registration closes at 9am on Monday October 25.

Should you have any questions, please email Jennifer Hsu (Manager, External Relations) at


Synthetic biology is bringing together engineers, physicists and biologists to model, design and construct biological circuits out of proteins, genes and other bits of DNA, and to use these circuits to rewire and reprogram organisms. These re-engineered organisms are going to change our lives in the coming years, leading to cheaper drugs, rapid diagnostic tests, and synthetic probiotics to treat infections and a range of complex diseases. In this talk, we highlight recent efforts to create synthetic gene networks and programmable cells, and discuss a variety of synthetic biology applications in biotechnology and biomedicine.

Professor James Collins is the Termeer Professor of Medical Engineering & Science and Professor of Biological Engineering at MIT, as well as a Member of the Harvard-MIT Health Sciences & Technology Faculty. He is also a Core Founding Faculty member of the Wyss Institute for Biologically Inspired Engineering at Harvard University, and an Institute Member of the Broad Institute of MIT and Harvard. He is one of the founders of the field of synthetic biology, and his research group is currently focused on using synthetic biology to create next-generation diagnostics and therapeutics. Professor Collins’ patented technologies have been licensed by over 25 biotech, pharma and medical devices companies, and he has co-founded a number of companies, including Synlogic, Senti Biosciences, Sherlock Biosciences and Cellarity, as well as Phare Bio, a non-profit focused on AI-driven antibiotic discovery. He has received numerous awards and honors, including a Rhodes Scholarship and a MacArthur “Genius” Award, and he is an elected member of all three national academies – the National Academy of Sciences, the National Academy of Engineering, and the National Academy of Medicine.
Lectures at the Leading Edge (LLE) is an annual lecture series hosted by the Department of Chemical Engineering & Applied Chemistry at the University of Toronto. LLE engages world-class researchers and thought leaders in Canada and around the world to spark conversations on the latest innovations in existing and emerging areas relevant to chemical engineering, applied chemistry and the engineering profession.
BUILDING A BIOTECH VENTURE November 4 @ 1:00 pm – 2:30 pm @ Online
Nov 4 @ 1:00 pm – 2:30 pm
BUILDING A BIOTECH VENTURE November 4 @ 1:00 pm - 2:30 pm @ Online

Join us on November 4th for an information session to learn about the Building a Biotech Venture Program.

Take your first steps toward entrepreneurship with the Building a Biotech Venture program, a program for trainees who are doing regenerative medicine- or precision medicine-related research in labs at the University of Toronto or its affiliated hospitals.

This year, Medicine by Design is offering this program in partnership with Precision Medicine Initiative (PRiME) as well as our foundational partners the Health Innovation Hub (H2i), a campus-linked accelerator at the Temerty Faculty of Medicine; and Talk Boutique.

Through a series of workshops over winter/spring 2022, teams will:

  • Learn how to think about their research in terms of a product or business;
  • Build a business canvas and develop their product or venture concept;
  • Receive guidance from industry experts on intellectual property, clinical translation, and early-stage stage investment.
  • Create a pitch deck and receive coaching on telling their venture story; and
  • Receive regular mentoring from entrepreneurs throughout the process.

The program will culminate in a pitch competition in May, where the first-place team will receive $25,000 and the second-place team will receive $10,000 in research funding to advance their product concept.Click here to read about HDAX Therapeutics, the team who received research funding as the winner of last year’s pitch competition.

To learn more about the program and how to apply, please join us virtually on November 4, 2021, from 1 p.m. to 2:30 p.m. EST for an information session. This session will provide an overview of the program and how to apply, as well as an introduction to H2i’s 10-point plan, which outlines 10 key elements of a business canvas.

Click here to read about HDAX Therapeutics, the team who received research funding as the winner of last year’s pitch competition.

If you have any immediate questions regarding this program, please contact Stephanie Hume (

This program will be offered virtually.

Building a Biotech Venture program breakdown:

  • Phase 1: Program Information Session and Team Building 
    November 4, 1 p.m. to 2:30 p.m.
    This session will provide an overview of the program and how to fill out the business one-pager, which is required to enroll, as well as an introduction to H2i’s 10-point plan, which outlines 10 key elements of a business canvas.

This session will be followed by a team building session the week of November 15 for trainees to build or add expertise to their teams. Stay tuned for more details.

*Phase 1 of the program will be open to all trainees within the Medicine by Design and PRiME communities.

  • Phase 2: Venture Development Workshops
    January-April 2022

The program will include workshops run by industry experts to help in scaling their ventures and prepare them for the pitch competition. The program will include workshops run by industry experts to help teams in scaling their ventures and prepare them for the pitch competition.

-Workshop 1: Mentor introduction Event (January)
-Workshop 2: Intellectual property (February)
-Workshop 3: Clinical translation and regulatory affairs (March)
-Workshop 4:  De-mystifying the pathway through to early-stage investment (March)
-Workshop 5: Pitching and presentation skills workshop (April)

*To apply to phase 2, teams must submit a one-page business canvas outlining their venture concept. Proposed product or venture concept must have an application to regenerative or precision medicine. Application documents to be provided post information session. 

*Each team must have at least one team member who’s current supervisor has a faculty appointment at U of T to be eligible for Phase 2.

  • Session 3: Medicine by Design Pitch Competition
    May 2022
    Select teams will pitch for a chance to receive $25,000 (first place) or $10,000 (second place) in research funding.
Seminar Series-Warren Grayson @ Online
Nov 9 @ 12:00 pm – 1:00 pm

Title: TBA

Presenter: Warren Grayson

Host: Penney Gilbert

Date: November 9, 2021

Time: 12:00pm – 1:00pm

Meeting Link:


Abstract:  TBA

Medicine By Design 6th Annual Symposium
Dec 9 @ 9:00 am – Dec 10 @ 12:00 pm

Event Details

Day 1: Thursday, December 9 — 9:00 a.m. to 1:30 p.m.
Day 2: Friday, December 10 — 10:00 a.m. to 12:00 p.m.

Join us for the sixth annual Medicine by Design symposium. The symposium will bring together principal investigators and trainees from across the University of Toronto and its affiliated hospitals, along with industry partners, the investment community, government, the not-for-profit sector and international collaborators. The theme of this year’s symposium is, “A Systems Approach to Regenerative Medicine.”

We will also hold a virtual poster session featuring the research of select trainees working on Medicine by Design-funded projects.

Day 1 Plenary Speakers

Session 1: Deciphering cell-cell communication

“Tissue homeostasis and inflammation”
Ruslan Medzhitov, PhD
Department of Immunobiology,
Yale School of Medicine

Session 2: Interconnected organs-on-chips

“Deconstructing the patient with systems biology, and reconstructing her with organs-on-chips”
Linda G. Griffith, PhD
Department of Biological and Medical Engineering,
Massachusetts Institute of Technology (MIT)

Day 2 Plenary Speaker and Panel

Session 3: Strengthening our bioinnovation ecosystem

“Lessons learned from COVID-19”
David R. Walt, PhD
Wyss Institute, Harvard University

Additional panellists

  • Catherine Beaudry – Partnership for the Organization of Innovation and New Technologies (4POINTO), Polytechnique Montreal
  • Michael May – CCRM
  • Beate Sander – Toronto Health Economics and Technology Assessment Collaborative (THETA), University Health Network

General Registration

Space is limited. Register at this link.  Registration will be open until Dec. 8 at 5 p.m. unless all spots are filled before that time.  If you have any questions, please email

Virtual Poster Session

The symposium will feature a virtual poster session to highlight the innovative research taking place in Medicine by Design-funded labs. Trainees in labs that have received funding from Medicine by Design, currently or in the past, can submit an abstract using the symposium registration form. The abstract submission deadline is Sunday, October 19 at 11:59 p.m. Symposium registration is automatic with poster abstract submission. Limit of one entry per Medicine-by Design funded lab.


All attendees are encouraged to browse the posters, which will be displayed on the virtual platform, at any time during the symposium. Trainees whose posters are featured in the session will be available to discuss their work on December 9, from 12:25 p.m. to 1:30 p.m.

Seminar Series- Kip Ludwig @ Online
Dec 14 @ 12:00 pm – 1:00 pm

Title: TBA

Presenter: Kip Ludwig

Host:  Kei Masani

Date: December 14, 2021

Time: 12:00pm – 1:00pm

Meeting Link:


Abstract:  TBA

Research streams

Innovation solutions for pressing healthcare challenges throughout the research and translational pipeline:


BME’s clinical engineers design technologies, devices and strategies for people with chronic disease, traumatic injury, disabilities and mobility limitations to help them integrate more fully with their environment.

Cell & Tissue

Research that has the potential to change how we think about disease and aging is happening at BME. Regenerative medicine uses stem cells and biomaterials to repair, replace or regenerate damaged tissue, organ structures and function.


BME researchers are advancing disease detection, customizing drug delivery and improving health-care outcomes with faster and more precise technologies and systems.

Research & professional degrees

Doctor of Philosophy

Research degree that exposes candidates to cutting-edge research in a laboratory

Master of Applied Science

Research degree that exposes candidates to cutting-edge research in a laboratory

Master of Engineering

Professional degree that exposes candidates to biomedical device design to commercialization

Listen to what our students have to say

We interviewed our students about what inspires them in research and extracurricular activities. Here are some of the faces of Biomedical Engineering

© 2021 Faculty of Applied Science & Engineering